Statera Biopharma Inc. Gains 62.84%

Thu, Oct 06, 2022 at 07:31 PM
Statera Biopharma Inc. Gains 62.84%

Statera Biopharma Inc. (STAB:NASDAQ) shot up at $0.23, representing a gain of 62.8%. On Thu, Oct 06, 2022, STAB:NASDAQ touched a New 2-Week High of $0.23. From Thu, Sep 22, 2022, the stock recorded 30.00% Up Days and 18.18% Green Days

The stock spiked on Thu, Oct 06, 2022 at $0.3 with a volume of 82M+.

About Statera Biopharma Inc. (STAB:NASDAQ)

Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.